indian patents act
5 Take-Home Points From India’s Historic Novartis Patent Case
The Indian Supreme Court ruling dismissing a patent application by Novartis for a new version of its leukemia drug raises five important points, writes Arvind Subramanian.
Novartis Loses Historic India Patent Case On Cancer Drug Glivec
After a seven year protracted battle, the Supreme Court of India has rejected a patent application by Swiss pharma giant Novartis for an updated version of its blockbuster drug.
OPINION: India Mustn’t Bow To Patent Pressure
The latest round of challenges to India's drug patent laws is a fight that must be won for the world's poor, says Priya Shetty.
India’s Patent Laws Threaten Public Health, U.K. Experts
Pending cases against India's patent laws threaten public health and misinterpret international IP agreements, say two public health experts from the U.K.
